Albendazole Market By Type ( Tablets, Capsules ), By End-use ( Ascaris Infection Treatment, Pinworm Infection Treatment ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 172

 ERC 4543

Albendazole Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

Albendazole is a WHO approved medication used for parasitic worm infestations. It is a broad spectrum medicine, which is also known by the name albendazolum. Albendazole is an orally administered drug that is recognized as an important and safe medicine required for the health system. The surging incidences of worm infestations, mainly among children and refugees is the main determinant that is boosting the sales of albendazole drug in the global market. The rural pockets of developing nations are the most prone areas exhibiting a rising graph of incidences regarding worm infestations. The scarcity of drinking water, poor hygiene conditions, and lack of proper sanitation in such areas of the world are the prime reasons for an increase in the parasitic worm infestations. In order to tackle such issues, in 2016, the Government of India started a nationwide deworming initiative. Under the deworming initiative, 27 crore children under the age of 1-19 year, covering 561 districts of India, were administered with albendazole tablets.

The global albendazole market is experiencing hurdles in its market growth due to the side effects of the medicine such as headaches, nausea, bone marrow suppression, and liver inflammation among others. In addition, pregnant women are not advised to consume albendazole as it is recognized as a pregnancy category C and category D drug in the US and Australia, respectively. The market is fragmented in nature with the presence of several market players offering their product by different brand name in the global market.

The report provides detailed qualitative and quantitative analysis of the global albendazole market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type, and end-use in each of the major regions of the world.

Global Albendazole Market Player Analysis -

The report presents detailed analysis of major players operating in global albendazole market. Few of them include CHANGZHOU YABANG, GlaxoSmithKline, Supharma Chem, HUBEI KEYI, Sequent Scientifi, Lasa Laboratory Pvt Ltd, K.A.Malle Pharmaceuticals, Leo Bio-Care Pvt., Salius Pharma, Fredun Pharmaceuticals Ltd, Hubei Zhongjia-chem Pharmaceutical, Ashish Life Science Pvt. Ltd., AdvacarePharma, MANAV DRUGS, and Huazhong Pharmaceutical. Detailed coverage on these market players with information on their revenue from albendazole business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Global albendazole market is segmented on the basis of type, end-use, and geography. On the basis of type, the market is categorized into tablets and capsules. By end-use, the market is segmented into ascaris infection treatment, pinworm infection treatment, and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Albendazole Market Segmentation

By Type
   • Tablets
   • Capsules

By End-use
   • Ascaris Infection Treatment
   • Pinworm Infection Treatment
   • Others

By Geography
   • North America
            o U.S.
            o Canada
            o Mexico
   • Europe
            o U.K
            o France
            o Germany
            o Italy
            o Spain
            o Rest of Europe
   • Asia-Pacific
            o China
            o Japan
            o India
            o Korea
            o Rest of APAC
   • South America
            o Brazil
            o Rest of South America
   • Rest of the World
            o Middle East
            o Africa

Albendazole Market Key Players

• CHANGZHOU YABANG
• GlaxoSmithKline
• Supharma Chem
• HUBEI KEYI
• Sequent Scientifi
• Lasa Laboratory Pvt Ltd
• K.A.Malle Pharmaceuticals
• Leo Bio-Care Pvt.
• Salius Pharma
• Fredun Pharmaceuticals Ltd
• Hubei Zhongjia-chem Pharmaceutical
• Ashish Life Science Pvt. Ltd.
• AdvacarePharma
• MANAV DRUGS
• Huazhong Pharmaceutical

Please fill in the form below to Request for Customized Report
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Albendazole Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Albendazole Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91-844-601-6060


  help@esticastresearch.com